# Study of Adavosertib(AZD1775) in Japanese Patients With Advanced Solid Tumours

> **NCT04462952** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 6 (actual)

## Conditions studied

- Advanced Solid Tumours

## Interventions

- **DRUG:** Adavosertib (AZD1775)

## Key facts

- **NCT ID:** NCT04462952
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-24
- **Primary completion:** 2021-09-22
- **Final completion:** 2021-09-22
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04462952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04462952, "Study of Adavosertib(AZD1775) in Japanese Patients With Advanced Solid Tumours". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04462952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*